Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 276

1.

Association of deficiency for mannan-binding lectin with anti-mannan antibodies in Crohn's disease: a family study.

Seibold F, Boldt AB, Seibold-Schmid B, Schoepfer AM, Flogerzi B, Müller S, Kun JF.

Inflamm Bowel Dis. 2007 Sep;13(9):1077-82.

PMID:
17480019
2.

Genetic variants of the mannan-binding lectin are associated with immune reactivity to mannans in Crohn's disease.

Seibold F, Konrad A, Flogerzi B, Seibold-Schmid B, Arni S, Jüliger S, Kun JF.

Gastroenterology. 2004 Oct;127(4):1076-84.

PMID:
15480986
3.

Low Mannan-binding lectin serum levels are associated with complicated Crohn's disease and reactivity to oligomannan (ASCA).

Schoepfer AM, Flogerzi B, Seibold-Schmid B, Schaffer T, Kun JF, Pittet V, Mueller S, Seibold F.

Am J Gastroenterol. 2009 Oct;104(10):2508-16. doi: 10.1038/ajg.2009.315. Epub 2009 Jun 16.

PMID:
19532127
4.

Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease.

Sendid B, Quinton JF, Charrier G, Goulet O, Cortot A, Grandbastien B, Poulain D, Colombel JF.

Am J Gastroenterol. 1998 Aug;93(8):1306-10.

PMID:
9707056
5.
6.

Mannose-binding lectin deficiency is not associated with anti-Saccharomyces cerevisiae antibody in Korean Crohn's disease patients.

Kim YS, Kim YH, Ye BD, Park DW, Kim JW, Han DS.

Clin Chim Acta. 2014 Feb 15;429:206-11. doi: 10.1016/j.cca.2013.12.019. Epub 2013 Dec 25.

PMID:
24374090
7.

Mannan-binding lectin deficiency results in unusual antibody production and excessive experimental colitis in response to mannose-expressing mild gut pathogens.

Müller S, Schaffer T, Flogerzi B, Seibold-Schmid B, Schnider J, Takahashi K, Darfeuille-Michaud A, Vazeille E, Schoepfer AM, Seibold F.

Gut. 2010 Nov;59(11):1493-500. doi: 10.1136/gut.2010.208348. Epub 2010 Aug 3.

PMID:
20682699
8.

Immune sensitization to yeast antigens in ASCA-positive patients with Crohn's disease.

Konrad A, Rütten C, Flogerzi B, Styner M, Göke B, Seibold F.

Inflamm Bowel Dis. 2004 Mar;10(2):97-105.

PMID:
15168808
9.

Inherited mannose-binding lectin deficiency as evidenced by genetic and immunologic analyses: association with severe recurrent infections.

Martin P, Lerner A, Johnson L, Lerner DL, Haraguchi S, Good RA, Day NK.

Ann Allergy Asthma Immunol. 2003 Oct;91(4):386-92.

PMID:
14582818
10.

Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.

Annese V, Piepoli A, Perri F, Lombardi G, Latiano A, Napolitano G, Corritore G, Vandewalle P, Poulain D, Colombel JF, Andriulli A.

Aliment Pharmacol Ther. 2004 Nov 15;20(10):1143-52.

11.

Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study.

Annese V, Andreoli A, Andriulli A, Dinca R, Gionchetti P, Latiano A, Lombardi G, Piepoli A, Poulain D, Sendid B, Colombel JF.

Am J Gastroenterol. 2001 Aug;96(8):2407-12.

PMID:
11513182
12.

Ethnic and socio-cultural specificities in Tunisia have no impact on the prevalence of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients, their relatives or associated clinical factors.

Hadrich I, Vandewalle P, Cheikhrouhou F, Makni F, Krichen MS, Sendid B, Standaert-Vitse A, Ayadi A, Poulain D.

Scand J Gastroenterol. 2007 Jun;42(6):717-25.

PMID:
17505994
13.

Mannan binding lectin (MBL) gene polymorphisms are not associated with anti-Saccharomyces cerevisiae (ASCA) in patients with Crohn's disease.

Joossens S, Pierik M, Rector A, Vermeire S, Ranst MV, Rutgeerts P, Bossuyt X.

Gut. 2006 May;55(5):746. No abstract available.

14.

Association of three systemic lupus erythematosus susceptibility factors, PD-1.3A, C4AQ0, and low levels of mannan-binding lectin, with autoimmune manifestations in Icelandic multicase systemic lupus erythematosus families.

Kristjansdottir H, Saevarsdottir S, Gröndal G, Alarcón-Riquelme ME, Erlendsson K, Valdimarsson H, Steinsson K.

Arthritis Rheum. 2008 Dec;58(12):3865-72. doi: 10.1002/art.24129.

15.

Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease: a family study.

Seibold F, Stich O, Hufnagl R, Kamil S, Scheurlen M.

Scand J Gastroenterol. 2001 Feb;36(2):196-201.

PMID:
11252413
16.

Functional characterization of the lectin pathway of complement in human serum.

Roos A, Bouwman LH, Munoz J, Zuiverloon T, Faber-Krol MC, Fallaux-van den Houten FC, Klar-Mohamad N, Hack CE, Tilanus MG, Daha MR.

Mol Immunol. 2003 Jan;39(11):655-68.

PMID:
12493641
17.

Analysis of the relationship between mannose-binding lectin (MBL) genotype, MBL levels and function in an Australian blood donor population.

Minchinton RM, Dean MM, Clark TR, Heatley S, Mullighan CG.

Scand J Immunol. 2002 Dec;56(6):630-41.

18.

Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction.

Vandewalle-El Khoury P, Colombel JF, Joossens S, Standaert-Vitse A, Collot M, Halfvarson J, Ayadi A, Landers CJ, Vermeire S, Rutgeerts P, Targan SR, Chamaillard M, Mallet JM, Sendid B, Poulain D.

Am J Gastroenterol. 2008 Apr;103(4):949-57. Epub 2007 Nov 28.

PMID:
18047546
19.

Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment.

Teml A, Kratzer V, Schneider B, Lochs H, Norman GL, Gangl A, Vogelsang H, Reinisch W.

Am J Gastroenterol. 2003 Oct;98(10):2226-31.

PMID:
14572572
20.

Mannose-binding lectin level and deficiency is not associated with inflammatory bowel diseases, disease phenotype, serology profile, and NOD2/CARD15 genotype in a large Hungarian cohort.

Papp M, Lakatos PL, Harsfalvi J, Farkas G, Palatka K, Udvardy M, Molnar T, Farkas K, Nagy F, Veres G, Lakatos L, Kovacs A, Dinya T, Kocsis AK, Papp J; Hungarian IBD Study Group., Altorjay I.

Hum Immunol. 2010 Apr;71(4):407-13. doi: 10.1016/j.humimm.2010.01.012. Epub 2010 Jan 26.

PMID:
20079790

Supplemental Content

Support Center